Shanghai Xiao Fang Pharmaceutical Co.,Ltd.

SHSE:603207 Stock Report

Market Cap: CN¥3.6b

Shanghai Xiao Fang PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 5/6

Shanghai Xiao Fang PharmaceuticalLtd has a total shareholder equity of CN¥699.2M and total debt of CN¥657.1K, which brings its debt-to-equity ratio to 0.09%. Its total assets and total liabilities are CN¥841.9M and CN¥142.7M respectively. Shanghai Xiao Fang PharmaceuticalLtd's EBIT is CN¥234.1M making its interest coverage ratio -296.9. It has cash and short-term investments of CN¥346.1M.

Key information

0.09%

Debt to equity ratio

CN¥657.13k

Debt

Interest coverage ratio-296.9x
CashCN¥346.08m
EquityCN¥699.17m
Total liabilitiesCN¥142.70m
Total assetsCN¥841.87m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 603207's short term assets (CN¥525.4M) exceed its short term liabilities (CN¥142.4M).

Long Term Liabilities: 603207's short term assets (CN¥525.4M) exceed its long term liabilities (CN¥295.5K).


Debt to Equity History and Analysis

Debt Level: 603207 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if 603207's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 603207's debt is well covered by operating cash flow (34877.4%).

Interest Coverage: 603207 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies